文献速递心力衰竭与心肌病心律失常瓣膜病与结构性心脏病

免疫检查点抑制剂的心血管毒性:JACC综述

Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

该综述总结了免疫检查点抑制剂(ICI)相关心血管不良事件(CVAE)的流行病学、病理生理机制和管理策略。心肌炎是ICI最常见的CVAE,心包疾病、Takotsubo综合征、心律失常和血管炎也构成其他重要不良事件。管理包括及时给予大剂量皮质类固醇,并在严重心肌炎时停用ICI,同时纳入NCCN指南要点。

要点

  • 心肌炎是ICI最常见的心血管不良事件。
  • 心包疾病、Takotsubo综合征、心律失常和血管炎也是显著不良事件。
  • 严重心肌炎需及时大剂量皮质类固醇并停用ICI。

核心结论

  • ICI相关心血管毒性虽不常见但可能致命,需提高认识并早期管理。

研究设计与样本

  • 综述总结了ICI相关CVAE的流行病学、病理生理机制和管理策略的最新证据,并纳入NCCN指南要点。

主要发现

  • 心肌炎是ICI最常见的心血管不良事件。
  • 心包疾病、Takotsubo综合征、心律失常和血管炎构成其他显著不良事件。

关键数值与推荐

  • 严重心肌炎的管理包括及时给予大剂量皮质类固醇并停用ICI。

临床怎么用

  • 临床医生应认识ICI相关的心血管毒性,对严重心肌炎及时使用大剂量皮质类固醇并停用ICI。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immune checkpoint inhibitors (ICIs) have been an important therapeutic advance in the field of cancer medicine, resulting in a significant improvement in survival of patients with advanced malignancies. Recent reports provided greater insights into the incidence of cardiovascular adverse events (CVAEs) with ICI use. Myocarditis is the most common CVAE associated with ICI. Pericardial diseases, Takotsubo syndrome, arrhythmias, and vasculitis constitute other significant AEs. Physicians should be aware of these infrequent, but potentially fatal toxicities associated with ICIs as their therapeutic use becomes widespread with a myriad of approvals by the U.S. Food and Drug Administration. Management involves prompt administration of high-dose corticosteroids and discontinuation of ICIs in severe myocarditis. This review summarizes the most updated evidence on epidemiology, pathophysiological mechanisms, and management strategies of various CVAEs associated with ICIs. Highlights from recent guidelines published by National Comprehensive Cancer Network on ICI-related CV toxicities have also been incorporated.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Ball S, Ghosh RK, Wongsaengsak S, et al. Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week. J Am Coll Cardiol. 2019. PMID: 31558256. doi:10.1016/j.jacc.2019.07.079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。